Financial Information for Guarantor Subsidiaries and Non-Guarantor Subsidiaries - Supplemental Condensed Consolidating Statement of Cash Flows (Details) - USD ($) $ in Millions | 3 Months Ended |
Mar. 31, 2019 | Mar. 31, 2018 |
Condensed Financial Statements | | |
Net cash (used in) provided by operating activities | $ 167 | $ 30 |
Cash flows from investing activities: | | |
Capital expenditures | (67) | (88) |
Acquisitions of businesses and assets, net of cash acquired | 0 | (274) |
Distributions of capital from equity investments | 3 | 2 |
Other, principally change in intercompany investing activities | 0 | 0 |
Net cash used in investing activities | (64) | (360) |
Cash flows from financing activities: | | |
Proceeds from long-term debt, net of payments | 953 | 5 |
Repayment of assumed NYX debt | 0 | (288) |
Payments of debt issuance and deferred financing costs | (14) | (39) |
Payments on license obligations | (7) | (7) |
Proceeds from Sale of Finance Receivables | 11 | |
Net redemptions of common stock under stock-based compensation plans and other | (1) | (17) |
Other, principally change in intercompany financing activities | 0 | 0 |
Net cash provided by (used in) financing activities | 942 | (346) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 1 | 2 |
Increase in cash, cash equivalents and restricted cash | 1,046 | (674) |
Cash, cash equivalents and restricted cash, beginning of period | 220 | 834 |
Cash, cash equivalents and restricted cash, end of period | 1,266 | 160 |
Reportable Legal Entities | SGI (Issuer) | | |
Condensed Financial Statements | | |
Net cash (used in) provided by operating activities | 55 | (25) |
Cash flows from investing activities: | | |
Capital expenditures | (10) | (17) |
Acquisitions of businesses and assets, net of cash acquired | | 0 |
Distributions of capital from equity investments | 0 | 0 |
Other, principally change in intercompany investing activities | (986) | 74 |
Net cash used in investing activities | (996) | 57 |
Cash flows from financing activities: | | |
Proceeds from long-term debt, net of payments | 955 | 7 |
Repayment of assumed NYX debt | | 0 |
Payments of debt issuance and deferred financing costs | (14) | (39) |
Payments on license obligations | 0 | 0 |
Proceeds from Sale of Finance Receivables | 0 | |
Net redemptions of common stock under stock-based compensation plans and other | 0 | 0 |
Other, principally change in intercompany financing activities | 0 | 0 |
Net cash provided by (used in) financing activities | 941 | (32) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 0 | 0 |
Increase in cash, cash equivalents and restricted cash | 0 | 0 |
Cash, cash equivalents and restricted cash, beginning of period | 2 | 1 |
Cash, cash equivalents and restricted cash, end of period | 2 | 1 |
Reportable Legal Entities | SGC (Parent) | | |
Condensed Financial Statements | | |
Net cash (used in) provided by operating activities | (15) | (32) |
Cash flows from investing activities: | | |
Capital expenditures | (3) | (8) |
Acquisitions of businesses and assets, net of cash acquired | | 0 |
Distributions of capital from equity investments | 0 | 0 |
Other, principally change in intercompany investing activities | 0 | 0 |
Net cash used in investing activities | (3) | (8) |
Cash flows from financing activities: | | |
Proceeds from long-term debt, net of payments | 0 | 0 |
Repayment of assumed NYX debt | | 0 |
Payments of debt issuance and deferred financing costs | 0 | 0 |
Payments on license obligations | (7) | (7) |
Proceeds from Sale of Finance Receivables | 0 | |
Net redemptions of common stock under stock-based compensation plans and other | 1 | (15) |
Other, principally change in intercompany financing activities | 1,069 | (630) |
Net cash provided by (used in) financing activities | 1,063 | (652) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 0 | 0 |
Increase in cash, cash equivalents and restricted cash | 1,045 | (692) |
Cash, cash equivalents and restricted cash, beginning of period | 74 | 732 |
Cash, cash equivalents and restricted cash, end of period | 1,119 | 40 |
Reportable Legal Entities | Guarantor Subsidiaries | | |
Condensed Financial Statements | | |
Net cash (used in) provided by operating activities | 63 | 34 |
Cash flows from investing activities: | | |
Capital expenditures | (25) | (45) |
Acquisitions of businesses and assets, net of cash acquired | | (9) |
Distributions of capital from equity investments | 0 | 0 |
Other, principally change in intercompany investing activities | (47) | 0 |
Net cash used in investing activities | (72) | (54) |
Cash flows from financing activities: | | |
Proceeds from long-term debt, net of payments | 0 | 0 |
Repayment of assumed NYX debt | | 0 |
Payments of debt issuance and deferred financing costs | 0 | 0 |
Payments on license obligations | 0 | 0 |
Proceeds from Sale of Finance Receivables | 11 | |
Net redemptions of common stock under stock-based compensation plans and other | (2) | (2) |
Other, principally change in intercompany financing activities | 0 | 22 |
Net cash provided by (used in) financing activities | 9 | 20 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 0 | 0 |
Increase in cash, cash equivalents and restricted cash | 0 | 0 |
Cash, cash equivalents and restricted cash, beginning of period | 44 | 44 |
Cash, cash equivalents and restricted cash, end of period | 44 | 44 |
Reportable Legal Entities | Non-Guarantor Subsidiaries | | |
Condensed Financial Statements | | |
Net cash (used in) provided by operating activities | 65 | 55 |
Cash flows from investing activities: | | |
Capital expenditures | (29) | (18) |
Acquisitions of businesses and assets, net of cash acquired | | (265) |
Distributions of capital from equity investments | 3 | 2 |
Other, principally change in intercompany investing activities | 0 | 0 |
Net cash used in investing activities | (26) | (281) |
Cash flows from financing activities: | | |
Proceeds from long-term debt, net of payments | (2) | (2) |
Repayment of assumed NYX debt | | (288) |
Payments of debt issuance and deferred financing costs | 0 | 0 |
Payments on license obligations | 0 | 0 |
Proceeds from Sale of Finance Receivables | 0 | |
Net redemptions of common stock under stock-based compensation plans and other | 0 | 0 |
Other, principally change in intercompany financing activities | (36) | 534 |
Net cash provided by (used in) financing activities | (38) | 244 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 1 | 2 |
Increase in cash, cash equivalents and restricted cash | 2 | 20 |
Cash, cash equivalents and restricted cash, beginning of period | 101 | 60 |
Cash, cash equivalents and restricted cash, end of period | 103 | 80 |
Eliminating Entries | | |
Condensed Financial Statements | | |
Net cash (used in) provided by operating activities | (1) | (2) |
Cash flows from investing activities: | | |
Capital expenditures | 0 | 0 |
Acquisitions of businesses and assets, net of cash acquired | | 0 |
Distributions of capital from equity investments | 0 | 0 |
Other, principally change in intercompany investing activities | 1,033 | (74) |
Net cash used in investing activities | 1,033 | (74) |
Cash flows from financing activities: | | |
Proceeds from long-term debt, net of payments | 0 | 0 |
Repayment of assumed NYX debt | | 0 |
Payments of debt issuance and deferred financing costs | 0 | 0 |
Payments on license obligations | 0 | 0 |
Proceeds from Sale of Finance Receivables | 0 | |
Net redemptions of common stock under stock-based compensation plans and other | 0 | 0 |
Other, principally change in intercompany financing activities | (1,033) | 74 |
Net cash provided by (used in) financing activities | (1,033) | 74 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 0 | 0 |
Increase in cash, cash equivalents and restricted cash | (1) | (2) |
Cash, cash equivalents and restricted cash, beginning of period | (1) | (3) |
Cash, cash equivalents and restricted cash, end of period | $ (2) | $ (5) |